Nature's Sunshine Products (NATR) AI Stock Analysis

• Market Cap: $242.49M
• Dividend Yield: N/A
• Average Volume (3M): 70.72K
• Price to Earnings (P/E): 18.9
• Beta (1Y): 0.65
• Revenue Growth: 4.33%
• EPS Growth: -6.33%
• Country: US
• Employees: 819
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.36
• Shares Outstanding: 17,635,551
• 10 Day Avg. Volume: 79,401
• 30 Day Avg. Volume: 70,715
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.00
• Enterprise Value/Revenue: 0.00
• Enterprise Value/Gross Profit: 0.00
• Enterprise Value/Ebitda: 0.00
• 1Y Price Target: $21.50
• Price Target Upside: 56.59% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: $15.00 ▲(9.25% Upside)

Nature's Sunshine Products receives a solid overall score driven by strong financial performance and a highly positive earnings call. While technical indicators suggest a bearish trend, the company's robust financial health and raised guidance provide a positive outlook. The valuation is reasonable, though the lack of a dividend yield may be a drawback for some investors.

Positive Factors

Revenue Growth

The significant increase in net sales, especially through digital channels, indicates strong market demand and effective sales strategies, supporting long-term growth.

Strong Cash Position

A strong cash position with no debt enhances financial stability, providing flexibility for strategic investments and cushioning against economic downturns.

Improved Gross Margin

Higher gross margins reflect effective cost management and pricing power, contributing to improved profitability and competitive positioning.

Negative Factors

Leadership Change

Leadership changes can introduce uncertainty and may disrupt strategic continuity, potentially impacting long-term execution and company culture.

Profitability Concerns

Low net profit margins indicate challenges in translating revenue into profit, which may affect the company's ability to reinvest and grow sustainably.

Tariff Impact

Tariffs can increase costs and pressure margins, potentially affecting competitiveness and profitability in international markets over the long term.

Nature's Sunshine Products Business Overview & Revenue Model

Company Description

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

How the Company Makes Money

Nature's Sunshine Products generates revenue primarily through the sale of its health and wellness products, which are marketed through a direct selling model. This model allows independent distributors to sell products directly to consumers, creating a network of sales representatives who earn commissions based on their sales volume. Key revenue streams include sales of dietary supplements, herbal products, and essential oils. The company also engages in strategic partnerships and collaborations to enhance its product offerings and expand its market reach. Additionally, Nature's Sunshine benefits from a loyal customer base and a growing trend towards natural and wellness-related products, which supports its earnings and overall financial performance.

Nature's Sunshine Products Financial Statement Overview

Summary

Nature's Sunshine Products demonstrates solid financial health with steady revenue growth, strong margins, and a robust balance sheet. While profitability ratios indicate room for improvement, the company's low leverage and strong cash flow position it well for future growth. Maintaining this trajectory could enhance profitability and shareholder value.

Income Statement

The income statement reveals steady revenue growth with a TTM revenue of $460.8 million, marking a 1.42% increase from the previous year. Gross profit margin is robust at 71.78%, indicating effective cost management. However, the net profit margin stands at 3.06%, suggesting limited profitability after expenses. The EBIT margin is 4.40% and EBITDA margin is 6.34%, reflecting moderate operational efficiency. Overall, the company shows a stable growth trajectory with room for improvement in profitability.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio of 0.10, demonstrating conservative leverage. Return on Equity (ROE) is 8.62%, indicating decent returns for shareholders. Equity ratio stands at 64.22%, highlighting a solid equity position and financial stability. Overall, the company maintains a healthy balance sheet with low risk and good equity utilization.

Cash Flow

Cash flow analysis shows positive free cash flow growth at 11.52% compared to the prior year, enhancing financial flexibility. The operating cash flow to net income ratio is 1.54, suggesting efficient cash generation relative to its earnings. The free cash flow to net income ratio is robust at 1.13, indicating strong cash conversion. Despite this, the company should focus on sustaining cash flow improvements to support future growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	460.82M	454.36M	445.32M	421.91M	444.08M	385.20M
Gross Profit	330.72M	324.69M	321.13M	299.76M	328.62M	283.93M
EBITDA	35.99M	32.79M	32.09M	31.15M	45.83M	32.23M
Net Income	14.11M	7.70M	15.08M	-390.00K	28.85M	21.34M
Balance Sheet
Total Assets	254.88M	240.85M	249.77M	229.78M	258.87M	249.50M
Cash, Cash Equivalents and Short-Term Investments	81.34M	84.70M	82.37M	60.03M	86.18M	92.07M
Total Debt	15.63M	14.20M	14.92M	19.18M	22.99M	26.33M
Total Liabilities	91.19M	79.86M	90.23M	82.73M	97.47M	92.26M
Stockholders Equity	157.68M	155.31M	154.06M	142.91M	158.20M	155.39M
Cash Flow
Free Cash Flow	15.98M	14.33M	30.75M	-6.92M	27.94M	32.75M
Operating Cash Flow	21.74M	25.30M	41.23M	710.00K	34.61M	37.66M
Investing Cash Flow	-5.76M	-10.97M	-10.48M	-7.63M	-6.61M	-4.91M
Financing Cash Flow	-14.16M	-9.90M	-7.96M	-16.25M	-31.72M	3.88M

Nature's Sunshine Products Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 13.73
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NATR, the sentiment is Negative. The current price of 13.73 is below the 20-day moving average (MA) of 14.08, below the 50-day MA of 15.41, and below the 200-day MA of 14.52, indicating a bearish trend. The MACD of -0.46 indicates Negative momentum. The RSI at 39.44 is Neutral, neither overbought nor oversold. The STOCH value of 65.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NATR.

Nature's Sunshine Products Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MAMA	76 Outperform	$436.58M	93.36	17.44%	―	19.34%	-12.64%
FTLF	72 Outperform	$186.41M	23.98	21.88%	―	3.91%	-1.39%
NATR	71 Outperform	$242.49M	18.95	9.15%	―	4.33%	-6.33%
LFVN	66 Neutral	$88.84M	9.27	33.31%	2.33%	16.77%	143.30%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
LSF	48 Neutral	$47.88M	-43.01	-8.34%	―	22.79%	74.00%
HAIN	43 Neutral	$100.22M	-0.18	-74.88%	―	-10.17%	-609.02%

Nature's Sunshine Products Corporate Events

Nature’s Sunshine Reports Strong Q3 2025 Results

Nature’s Sunshine Products, Inc., a prominent player in the natural health and wellness industry, specializes in manufacturing and distributing high-quality herbal and nutritional supplements across more than 40 countries. In its latest earnings report for the third quarter of 2025, the company announced a significant increase in net sales and profitability. Net sales rose by 12% to $128.3 million, while the GAAP earnings per share saw a 30% increase to $0.30. The adjusted EBITDA also experienced a substantial rise of 42%, reaching $15.2 million.

Nature’s Sunshine Products Explores Cognitive Benefits with New Study

Nature’s Sunshine Products is conducting a study titled ‘Evaluation of Acute Cognitive Effects of Brain Edge on Healthy Volunteers.’ The study aims to assess the cognitive benefits of Brain Edge, a dietary supplement, on healthy adults. This research is significant as it explores potential enhancements in cognitive health and mood.

Nature’s Sunshine Appoints Kenneth Romanzi as New CEO

On October 15, 2025, Nature’s Sunshine Products announced the appointment of Kenneth Romanzi as the new Chief Executive Officer, effective October 29, 2025, succeeding Terrence O. Moorehead. Romanzi, with over 40 years of experience in the consumer-packaged goods industry, is expected to drive growth and innovation for the company, leveraging his extensive leadership background. This leadership change is part of the company’s strategic efforts to enhance its market position and accelerate its growth trajectory, aiming to expand its digital and omnichannel offerings globally.

The most recent analyst rating on (NATR) stock is a Hold with a $16.50 price target. To see the full list of analyst forecasts on Nature’s Sunshine Products stock, see the NATR Stock Forecast page.